Carbapenem-resistant Acinetobacter baumannii are recognised
by the US Centers for Disease Control and Prevention (CDC) as an
urgent threat [1]. The most prevalent mechanism of carbapenem
resistance in Acinetobacter spp. is due to the presence of
carbapenem-hydrolysing class D β-lactamases, with OXA-23 being
the most common. The observed dispersion of blaOXA-23 is
attributed in part to the spread of successful A. baumannii global
clones such as GC1 and GC2 [2]. However, in the most recent years
an increased emergence of blaNDM-1-harbouring Acinetobacter spp.
isolates has been reported